Cargando…

Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing

BACKGROUND: Trimethylaminuria (TMAU) is a genetic disorder whereby people cannot convert trimethylamine (TMA) to its oxidized form (TMAO), a process that requires the liver enzyme FMO3. Loss-of-function variants in the FMO3 gene are a known cause of TMAU. In addition to the inability to metabolize T...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yiran, Hwang, Liang-Dar, Li, Jiankang, Eades, Jason, Yu, Chung Wen, Mansfield, Corrine, Burdick-Will, Alexis, Chang, Xiao, Chen, Yulan, Duke, Fujiko F., Zhang, Jianguo, Fakharzadeh, Steven, Fennessey, Paul, Keating, Brendan J., Jiang, Hui, Hakonarson, Hakon, Reed, Danielle R., Preti, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310055/
https://www.ncbi.nlm.nih.gov/pubmed/28196478
http://dx.doi.org/10.1186/s12881-017-0369-8
_version_ 1782507810536292352
author Guo, Yiran
Hwang, Liang-Dar
Li, Jiankang
Eades, Jason
Yu, Chung Wen
Mansfield, Corrine
Burdick-Will, Alexis
Chang, Xiao
Chen, Yulan
Duke, Fujiko F.
Zhang, Jianguo
Fakharzadeh, Steven
Fennessey, Paul
Keating, Brendan J.
Jiang, Hui
Hakonarson, Hakon
Reed, Danielle R.
Preti, George
author_facet Guo, Yiran
Hwang, Liang-Dar
Li, Jiankang
Eades, Jason
Yu, Chung Wen
Mansfield, Corrine
Burdick-Will, Alexis
Chang, Xiao
Chen, Yulan
Duke, Fujiko F.
Zhang, Jianguo
Fakharzadeh, Steven
Fennessey, Paul
Keating, Brendan J.
Jiang, Hui
Hakonarson, Hakon
Reed, Danielle R.
Preti, George
author_sort Guo, Yiran
collection PubMed
description BACKGROUND: Trimethylaminuria (TMAU) is a genetic disorder whereby people cannot convert trimethylamine (TMA) to its oxidized form (TMAO), a process that requires the liver enzyme FMO3. Loss-of-function variants in the FMO3 gene are a known cause of TMAU. In addition to the inability to metabolize TMA precursors like choline, patients often emit a characteristic odor because while TMAO is odorless, TMA has a fishy smell. The Monell Chemical Senses Center is a research institute with a program to evaluate people with odor complaints for TMAU. METHODS: Here we evaluated ten subjects by (1) odor evaluation by a trained sensory panel, (2) analysis of their urine concentration of TMA relative to TMAO before and after choline ingestion, and (3) whole exome sequencing as well as subsequent variant analysis of all ten samples to investigate the genetics of TMAU. RESULTS: While all subjects reported they often emitted a fish-like odor, none had this malodor during sensory evaluation. However, all were impaired in their ability to produce >90% TMAO/TMA in their urine and thus met the criteria for TMAU. To probe for genetic causes, the exome of each subject was sequenced, and variants were filtered by genes with a known (FMO3) or expected effect on TMA metabolism function (other oxidoreductases). We filtered the remaining variants by allele frequency and predicated functional effects. We identified one subject that had a rare loss-of-function FMO3 variant and six with more common decreased-function variants. In other oxidoreductases genes, five subjects had four novel rare single-nucleotide polymorphisms as well as one rare insertion/deletion. Novel in this context means no investigators have previously linked these variants to TMAU although they are in dbSNP. CONCLUSIONS: Thus, variants in genes other than FMO3 may cause TMAU and the genetic variants identified here serve as a starting point for future studies of impaired TMA metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-017-0369-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5310055
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53100552017-03-13 Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing Guo, Yiran Hwang, Liang-Dar Li, Jiankang Eades, Jason Yu, Chung Wen Mansfield, Corrine Burdick-Will, Alexis Chang, Xiao Chen, Yulan Duke, Fujiko F. Zhang, Jianguo Fakharzadeh, Steven Fennessey, Paul Keating, Brendan J. Jiang, Hui Hakonarson, Hakon Reed, Danielle R. Preti, George BMC Med Genet Research Article BACKGROUND: Trimethylaminuria (TMAU) is a genetic disorder whereby people cannot convert trimethylamine (TMA) to its oxidized form (TMAO), a process that requires the liver enzyme FMO3. Loss-of-function variants in the FMO3 gene are a known cause of TMAU. In addition to the inability to metabolize TMA precursors like choline, patients often emit a characteristic odor because while TMAO is odorless, TMA has a fishy smell. The Monell Chemical Senses Center is a research institute with a program to evaluate people with odor complaints for TMAU. METHODS: Here we evaluated ten subjects by (1) odor evaluation by a trained sensory panel, (2) analysis of their urine concentration of TMA relative to TMAO before and after choline ingestion, and (3) whole exome sequencing as well as subsequent variant analysis of all ten samples to investigate the genetics of TMAU. RESULTS: While all subjects reported they often emitted a fish-like odor, none had this malodor during sensory evaluation. However, all were impaired in their ability to produce >90% TMAO/TMA in their urine and thus met the criteria for TMAU. To probe for genetic causes, the exome of each subject was sequenced, and variants were filtered by genes with a known (FMO3) or expected effect on TMA metabolism function (other oxidoreductases). We filtered the remaining variants by allele frequency and predicated functional effects. We identified one subject that had a rare loss-of-function FMO3 variant and six with more common decreased-function variants. In other oxidoreductases genes, five subjects had four novel rare single-nucleotide polymorphisms as well as one rare insertion/deletion. Novel in this context means no investigators have previously linked these variants to TMAU although they are in dbSNP. CONCLUSIONS: Thus, variants in genes other than FMO3 may cause TMAU and the genetic variants identified here serve as a starting point for future studies of impaired TMA metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-017-0369-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-15 /pmc/articles/PMC5310055/ /pubmed/28196478 http://dx.doi.org/10.1186/s12881-017-0369-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Guo, Yiran
Hwang, Liang-Dar
Li, Jiankang
Eades, Jason
Yu, Chung Wen
Mansfield, Corrine
Burdick-Will, Alexis
Chang, Xiao
Chen, Yulan
Duke, Fujiko F.
Zhang, Jianguo
Fakharzadeh, Steven
Fennessey, Paul
Keating, Brendan J.
Jiang, Hui
Hakonarson, Hakon
Reed, Danielle R.
Preti, George
Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
title Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
title_full Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
title_fullStr Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
title_full_unstemmed Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
title_short Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
title_sort genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310055/
https://www.ncbi.nlm.nih.gov/pubmed/28196478
http://dx.doi.org/10.1186/s12881-017-0369-8
work_keys_str_mv AT guoyiran geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT hwangliangdar geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT lijiankang geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT eadesjason geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT yuchungwen geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT mansfieldcorrine geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT burdickwillalexis geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT changxiao geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT chenyulan geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT dukefujikof geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT zhangjianguo geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT fakharzadehsteven geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT fennesseypaul geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT keatingbrendanj geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT jianghui geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT hakonarsonhakon geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT reeddanieller geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing
AT pretigeorge geneticanalysisofimpairedtrimethylaminemetabolismusingwholeexomesequencing